Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry [Book Review]
Journal of Business Ethics 105 (2):239-255 (2012)
AbstractThe outsourcing of medical research has become a strategic imperative in the global pharmaceutical industry. Spurred by the challenges of competition, the need for speed in drug development, and increasing domestic costs, pharmaceutical companies across the globe continue to outsource critical parts of their value chain activities, namely contract clinical research and drug testing, to sponsors across the globe, typically into emerging markets. While it is clear that important ethical issues arise with this practice, unraveling moral responsibility and the allocation of responsibility is not so clear, considering that contracts, by their very definition transfer responsibility from the principal to the agent. This research provides a framework for exploring some of the ethical issues, including attributions of moral responsibility associated with Contract Medical Research. Using a theory of strategic and moral behavior, the research shows that both clients and sponsors in contract research have individual and collective responsibility to ensure that due care and diligence is exercised in the performance of clinical research. The research suggests some guidelines for stakeholder action.
Added to PP
Historical graph of downloads
References found in this work
Doing & Deserving; Essays in the Theory of Responsibility.Joel Feinberg - 1970 - Princeton: Princeton University Press.
Causation in the Law.Herbert Lionel Adolphus Hart & Tony Honoré - 1959 - Oxford University Press UK.
Causal Judgment and Moral Judgment: Two Experiments.Joshua Knobe & Ben Fraser - 2008 - In Walter Sinnott-Armstrong (ed.), Moral Psychology. MIT Press.
Citations of this work
Communicating Moral Legitimacy in Controversial Industries: The Trade in Human Tissue.A. Rebecca Reuber & Anna Morgan-Thomas - 2019 - Journal of Business Ethics 154 (1):49-63.
Vulnerability, Moral Responsibility, and Moral Obligations: The Case of Industrial Action in the Medical and Allied Professions.Henry Adobor - 2022 - Medicine, Health Care and Philosophy 25 (3):333-349.
The Abandoned Stakeholders: Pharmaceutical Companies and Research Participants.Pepe Chang - 2017 - Journal of Business Ethics 143 (4):721-731.
Similar books and articles
Legal, Regulatory and Ethical Dimensions of Mandatory Clinical Trial Registration.Ron A. Bouchard - manuscript
Manual for Research Ethics Committees: Centre of Medical Law and Ethics, King's College London.Sue Eckstein (ed.) - 2003 - Cambridge University Press.
Understanding Physician-Pharmaceutical Industry Interactions: A Concise Guide.Shaili Jain - 2007 - Cambridge University Press.
Vioxx and Other Pharmaceutical Product Withdrawals: Ethical Issues in Ensuring the Integrity of Drug and Medical Device Research, Development and Commercialization.K. L. Phua & F. I. Achike - 2007 - Clinical Ethics 2 (3):155-162.
Clarifying Confusions About Coercion.Jennifer Susan Hawkins & Ezekiel J. Emanuel - 2005 - Hastings Center Report 35 (5):16-19.
Pharmaceutical Companies and Access to Medicines – Social Integration and Ethical CSR Resolution of a Global Public Choice Problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Gifts, Drug Samples, and Other Items Given to Medical Specialists by Pharmaceutical Companies.Paul M. McNeill, Ian H. Kerridge, Catherine Arciuli, David A. Henry, Graham J. Macdonald, Richard O. Day & Suzanne R. Hill - 2006 - Journal of Bioethical Inquiry 3 (3):139-148.
Dangerous Medicine: The Pharmaceutical Industry's Questionable Ethical Practices.John T. Fielding - unknown
The Development of Contemporary Medical Genetics Research Models and the Need for Scientific Responsibility.Jennifer Marshall - unknown
Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions.Murray Joseph Casey, Richard O'Brien, Marc Rendell & Todd Salzman - 2012 - American Journal of Bioethics 12 (7):34 - 37.
Conflicts of Interest in Drug Development: The Practices of Merck & Co., Inc.Laurence J. Hirsch - 2002 - Science and Engineering Ethics 8 (3):429-442.
Issues and Challenges in Research on the Ethics of Medical Tourism: Reflections From a Conference. [REVIEW]Jeremy Snyder, Valorie Crooks & Leigh Turner - 2011 - Journal of Bioethical Inquiry 8 (1):3-6.